Eotaxin-3 (CCL26) Expression in Human Pancreatic Myofibroblasts

Area of Science:

• Immunology
• Gastroenterology
• Cell Biology

Background:

• Eosinophil infiltration is a key feature of autoimmune pancreatitis (AIP).
• The precise mechanisms driving eosinophilic infiltration in AIP remain largely unexplored.
• Understanding these mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the expression of eotaxin-3, a potent eosinophil chemoattractant, in human pancreatic myofibroblasts.
• To elucidate the signaling pathways involved in eotaxin-3 induction in pancreatic myofibroblasts.

Main Methods:

• Quantification of eotaxin-3 protein and mRNA levels using enzyme-linked immunosorbent assays (ELISA) and quantitative polymerase chain reactions (qPCR).
• Investigation of the role of T helper type 2 cytokines (IL-4, IL-13) and interferon-gamma (IFN-γ) in eotaxin-3 induction.
• Analysis of the involvement of STAT6 and STAT1 signaling pathways using small interfering RNA (siRNA) and Western blotting.

Main Results:

• Interleukin-4 (IL-4) and IL-13 significantly induced eotaxin-3 expression in pancreatic myofibroblasts in a time- and dose-dependent manner.
• IL-4 and IL-13 triggered STAT6 phosphorylation, and STAT6-specific siRNA blocked eotaxin-3 induction, confirming STAT6 pathway involvement.
• Suppressor of cytokine signaling (SOCS) proteins negatively regulated eotaxin-3 expression, while interferon-gamma (IFN-γ) inhibited it via STAT1 activation.

Conclusions:

• Human pancreatic myofibroblasts are a significant cellular source of eotaxin-3 in the pancreas.
• T helper type 2 cytokines, IL-4 and IL-13, are critical inducers of eotaxin-3 expression.
• These findings provide insights into the pathogenesis of eosinophilic inflammation in pancreatic diseases.